EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Perspective Therapeutics, Inc. (CATX) EBITDA Margin data is not available.
| Income Statement Financials | |
$0.08M |
|
$-26.19M |
|
-- |
|
$0.08M |
|
$28.36M |
|
$-28.28M |
|
$2.09M |
|
$-26.19M |
|
$-26.19M |
|
$-26.19M |
|
$-26.19M |
|
$-26.19M |
|
$-26.19M |
|
$-28.28M |
|
$-27.64M |
|
103.60M |
|
103.60M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$275.35M |
|
$92.48M |
|
$135.42M |
|
$410.77M |
|
$31.49M |
|
$1.55M |
|
$31.84M |
|
$63.33M |
|
$347.44M |
|
$307.44M |
|
$347.44M |
|
114.02M |
|
| Cash Flow Statement Financials | |
$-31.47M |
|
$-109.55M |
|
$164.36M |
|
$30.63M |
|
$53.97M |
|
$23.34M |
|
$2.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.75 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-37211.84% |
|
-37211.84% |
|
|
EBITDA Margin |
-- |
-34459.21% |
|
-34459.21% |
|
$-38.33M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.31 |
|
68.68 |
|
-7.54% |
|
-8.52% |
|
-6.38% |
|
-7.50% |
|
$3.05 |
|
$-0.37 |
|
$-0.30 |
|